of seven cytochalasans including cytochalasins B, D and E and novel phenochalasins A and B were tested on cytosolic lipid droplet formation and neutral lipid synthesis in mouse peritoneal macrophages. Phenochalasin A inhibited lipid droplet formation in a dose-dependent manner at least up to 20^mwithout any morphological changes in macrophages. Cytochalasins D and E also inhibited lipid droplet formation only in a narrow range of concentrations, around 1 and 0. 1 jum, respectively. At higher concentrations they gave morphological changes in macrophages. The other four cytochalasans only showedsevere morphological changes in macrophages. Phenochalasin A and cytochalasins D and E inhibited cholesteryl ester (CE) synthesis specifically with IC50 values of 0.61, 2.4 and 0.20/xm, respectively, while the other cytochalasans inhibited both CEand triacylglycerol syntheses.
phenochalasins A and B were tested on cytosolic lipid droplet formation and neutral lipid synthesis in mouse peritoneal macrophages. Phenochalasin A inhibited lipid droplet formation in a dose-dependent manner at least up to 20^mwithout any morphological changes in macrophages. Cytochalasins D and E also inhibited lipid droplet formation only in a narrow range of concentrations, around 1 and 0. 1 jum, respectively. At higher concentrations they gave morphological changes in macrophages. The other four cytochalasans only showedsevere morphological changes in macrophages. Phenochalasin A and cytochalasins D and E inhibited cholesteryl ester (CE) synthesis specifically with IC50 values of 0.61, 2.4 and 0.20/xm, respectively, while the other cytochalasans inhibited both CEand triacylglycerol syntheses.
Thus, among the cytochalasans tested, phenochalasin A showed very specific inhibition of CE synthesis and gave the lowest morphological changes in macrophages, resulting in the best inhibitor of lipid droplet formation in macrophages.
In the early stages of atherosclerogenesis, macrophages penetrate into the intima, efficiently take up modified low density lipoprotein (LDL), store cholesterol and fatty acids macrophages. This paper shows that phenochalasin A is the most specific inhibitor of mousemacrophage-derived foam cell formation amongthe cytochalasans tested.
Materials and Methods

Material s
Phenochalasins A and B were purified from the culture broth of Phomopsis sp. FT-021 1 as reported previously5). Aspochalasins F and G were purified from the culture broth (à") were separated on a TLCand determined with a radioscanner as described in the "Materials and Methods". The results are plotted as % of control (without a drug).
Results
Effect of Cytochalasans on Lipid Droplet Formation in Macrophages
Whenmouse peritoneal macrophages were incubated with liposomes, a number of lipid droplets were observed in cytosols of macrophages ( Fig. 2A) . Phenochalasin A inhibited lipid droplet formation in a dose-dependent manner at least up to 20jum in that the size and the number of lipid droplets decreased ( Fig. 2C and D) . Cytochalasins D and E showed moderate inhibition of the lipid droplet formation at 1.0 and 0.1 jlim (data not shown), but caused morphological changes in macrophages at 10 (Fig. 2E ) and 1.0/im (Fig. 2F) caused no effect even at 19 jum, while the others including cytochalasin D produced morphological changes in macrophages at 0.18-2.4/im ( Table 1) . As a result, phenochalasin A was found to give the lowest effect on mouse macrophages in both MTT and morphological analyses amongthe seven cytochalasans.
Effect ofPhenochalasin A on the Metabolism of (Table 1) . Taken together, phenochalasin A is the best inhibitor of lipid droplet formation in mousemacrophagesdue to the JAN. 2000 specific inhibition of CE synthesis and the lowest cytotoxic effect amongcytochalasans tested. Although phenochalasin A blocked prelysosomal stages of the cholesterol metabolism as well as cytochalasin D (Fig. 3) , the inhibition site of phenochalasin A seems different from that of cytochalasin D because of different effects on macrophage morphology. Further studies on the effect of phenochalasin A on actin cytoskeleton and the inhibition site in lipid droplet formation remain to be investigated. 
